Print this page
-
Concordance of self-reported Race and Ethnicity with Hospital Records Among Pediatric Patients
Protocol: 112001Principal Investigator:
- Peter Cole M.D. (Rutgers University)
Applicable Disease Sites: Any Site -
Improving chemotherapy-induced nausea control through Bright Ideas?-CIN training: a feasibility study in children receiving oral chemotherapy
Protocol: 132104Principal Investigator:
- Katie Devine (Rutgers University)
Applicable Disease Sites: Leukemia, not otherwise specified
Leukemia, other -
Targeted Genomic Analysis of Human Cancers
Protocol: 001209Principal Investigator:
- Shridar Ganesan MD, PhD (Rutgers University)
Applicable Disease Sites: Any Site -
Novel Immune Checkpoint Expression on Circulating Tumor Cells of Sarcomas
Protocol: 112103Principal Investigator:
- Scott Moerdler M.D. (Rutgers University)
Applicable Disease Sites: Soft Tissue -
Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies.
Protocol: 072014Principal Investigator:
- Seth Cohen MD (Monmouth Medical Center)
Applicable Disease Sites: Any Site -
Phase 1 Study To Evaluate the Safety and Pharmacokinetics of Palbociclib (IBRANCE?) in Combination with Irinotecan (IRN) and Temozolomide (TMZ) in Pediatric Patients with Recurrent or Refractory Solid Tumors.
Protocol: 111901Principal Investigator:
- Scott Moerdler M.D. (Rutgers University)
Applicable Disease Sites: Any Site
